Search results

Page results

• Access to the paediatric emergency department into the new year

  Whilst the UCLH paediatric emergency department remains on divert, access for GPs to paediatrics remains available as usual.

• Advice for patients before they are admitted to UCLH

  We are asking patients to follow some protocols before they come to UCLH and would appreciate it if you could reiterate this with your patients when you refer them.

• Covid-19 NHS vaccination centre opens at Francis Crick Institute

  UCLH and The Francis Crick Institute have formed a partnership to deliver a new large-scale COVID-19 vaccination centre at the Institute.

• Outpatient Hysteroscopy

  https://www.uclh.nhs.uk/patients-and-visitors/patient-information-pages/outpatient-hysteroscopy#

• Paediatric patients – advice and support for GPs over Christmas

  We want to make you aware that our children and young people’s teams will be available throughout the holiday period to provide advice and support when needed.

• Infection Inpatients

  Infection inpatients offers a variety of different specialities including Infectious Diseases and Tropical Medicine, Respiratory Medicine and Rheumatology. We are also the inpatient ward to the Hospital of Tropical Diseases.

• Patient/carer governors

  Information about the elected council of governors for UCLH - patient governors

• Judicial review outcome: puberty blocking treatment for children

  The High Court has today ruled in favour of a judicial review claim which means children and young people may not be able to consent to hormone-blocking treatment in cases of gender dysphoria.

• UCLH and The Business Design Centre deliver new large scale vaccination centre

  UCLH has formed a partnership with the Business Design Centre in Islington to deliver a second COVID-19 large scale vaccination centre.

• $175.5 million for immunotherapy spin-out to develop new treatments

  Achilles Therapeutics, a company built on research at UCLH, UCL Cancer Institute and the Francis Crick Institute has successfully raised $175.5 million through its initial public offering in the United States.